Until now, the most effective GLP-1 weight loss treatments have mainly been weekly injections, which can put some patients off due to needle anxiety, inconvenience or stigma
While Medicare drug plans can add new drugs to their formularies during the year to reflect new approvals and expanded indications, plans are not required to cover every new drug that comes to market
At Frisco Quick Care, your safety and well-being are our top priorities
In adults with type 2 diabetes, treatment with tirzepatide 5 mg, 10 mg and 15 mg once weekly was associated with superior weight reduction from baseline compared with placebo, semaglutide 1 mg weekly, titrated insulin degludec, titrated insulin glargine and titrated insulin lispro as an add-on to insulin glargine
Zepbound ( Tirzepatide ) Zepbound is a newer medication that combines both GLP-1 and GIP receptor agonist actions, impacting not only appetite but also other metabolic pathways